WHO Declares Ebola a Global Health Emergency

Synopsis

On 16 May 2026, the Ebola disease outbreak in the Democratic Republic of the Congo and Uganda was declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization. It has been triggered by a rare strain of the virus called Bundibugyo, which has no licensed vaccine or specific medication to treat it, and has resulted in over 300 suspected infections and more than 88 deaths, including cross-border transmission to the Uganda capital, Kampala.

The alert was for a pathogen that is uncommon and poorly understood

The World Health Organization (WHO) was notified on 5 May 2026 of an outbreak of unknown aetiology in the Mongbwalu Health Zone of Ituri Province, northeastern Democratic Republic of the Congo (DRC) with high levels of mortality. Included in the dead were health workers, which immediately raised the alarm in global health architecture, as it raised the possibility of healthcare-associated transmission.

The causative pathogen was lab-confirmed at the Institut National de Recherche Biomédicale (INRB) in Kinshasa on 15 May 2026 to be the Bundibugyo virus, a species of orthoebolavirus first identified in Uganda's Bundibugyo district in 2007. On the same day, the DRC's Ministry of Public Health, Hygiene and Social Welfare officially declared it the country's 17th outbreak of Ebola.

WHO Director-General Tedros Adhanom Ghebreyesus, under the provisions of the International Health Regulations (2005), declared the outbreak a Public Health Emergency of International Concern (PHEIC) — the second highest alert classification, second only to a Pandemic Emergency — one day later on 16 May.

The Bundibugyo Strain: What Makes It Distinct and Dangerous

The Bundibugyo virus is a highly unusual strain of the Ebola virus. It has only been reported in two previous outbreaks, in Uganda in 2007 and in the DRC in 2012. These events had case fatality rates between 30 and 50 per cent and thus are among the most deadly pathogens known to clinical medicine.

The reason that the current outbreak is different from previous Ebola outbreaks in the DRC is that there have been no medical countermeasures against the Zaire ebolavirus. The rVSV-ZEBOV vaccine and the monoclonal antibodies REGN-EB3 and mAb114 have been shown to be effective against Ebola-Zaire, but no vaccines or specific therapy have been licensed for the treatment of Bundibugyo virus disease.

Both WHO and the U.S. Centers for Disease Control and Prevention (CDC) emphasized this as an important factor in deciding the response approach. The WHO commented that supportive care is life-saving, especially in the absence of specific therapies.

The Epidemiological picture: Cases, death and cross-border spread

On 16th May 2026, official information reported 8 laboratory confirmed cases, 246 suspected cases and 80 suspected deaths in at least 3 health zones in Ituri province namely Bunia, Rwampara and Mongbwalu. Community fatalities of people who had symptomatic signs of Bundibugyo virus disease had been reported in several other health zones and there were suspected cases in Ituri and North Kivu.

The situation grew far more dire after two imported cases were confirmed in the capital, Kampala, with populations of more than four million, on 15 May 2026 and 16 May 2026. Both were from the DRC. The WHO said there was no epidemiological link between the two cases at the time it was reported, but there was no local transmission found in Uganda.

A second confirmed case was then reported in Goma, one of the largest cities in the eastern DRC province controlled by the Rwanda-backed M23 rebel group, the wife of a man who had died of the disease in Bunia, who had been travelling to Goma when he was infected.

The total as of the last update from the CDC was 10 confirmed cases and 336 suspected cases with 88 deaths in the DRC and 2 confirmed cases with one death in Uganda. These are subject to revision upwards because more surveillance provides a more accurate picture.

There are issues related to conflict, mobility and surveillance gaps that need to be compounded

A set of structural factors was identified through the WHO risk assessment, which significantly increases the chances of further spread. Ituri Province is the epicentre of the outbreak and is located in the eastern region of DRC, a hotspot of an ongoing humanitarian crisis for years characterised by active armed conflict, large-scale population displacement and a health infrastructure in poor condition.

This current hotspot's insecurity, humanitarian crisis, high population mobility, the urban or semi-urban nature of the situation and the large network of informal healthcare facilities further compound the risk of spread, the WHO warned, making a clear connection with the catastrophic North Kivu-Ituri outbreak in 2018-2019 which claimed nearly 2,300 lives.

The large proportion of those who were positive in laboratory tests in the initial few samples taken in multiple locations – eight out of 13 – prompted the WHO to warn that the outbreak may be much bigger than what is being "detected and reported."

A global response has been carried out by CDC, ECDC, and diplomatic pressures.

In response, the United States CDC responded quickly to coordinate response activities with the DRC and Uganda Ministries of Health. The CDC said the danger to the public is still low at this time and can't be spread through casual contact or by the air.

The European Centre for Disease Prevention and Control (ECDC) calculated the probability of infection for the citizens of the EU and EEA as "very low," but they pointed out that there is increased risk in neighbouring countries with land borders with the DRC because of population movement, trade, and travel.

To prevent people and goods from passing through unmonitored crossing points, as happened during previous outbreaks, WHO recommended against closing borders and restricting trade. It did, however, recommend the immediate isolation of confirmed cases and cross-border health checks at key road checkpoints.

Preparing for the future: Research, vaccines and race to the spread

A declaration of a PHEIC activates a series of legal responsibilities under the International Health Regulations. An Emergency Committee has been set up to make temporary recommendations to State Parties. One of the priorities that WHO has set is to speed up the research and clinical trials to find potential therapies or vaccine candidates in the case of BVD.

Since the discovery of Ebola near the Ebola River in 1976, the DRC has been the country to have had 17 outbreaks. About 15,000 people have died from the disease worldwide, most of them in Africa. The outbreak is the first case of Ebola's least medically understood of its main strains in one of the world's most conflict-stricken areas, posing an epidemiological, logistical and political challenge to the global health community.